Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease

Journal of Infectious Diseases

Volumn 191, Issue 1, 2005, Pages 4-10

  Yoo, Thomas W ^a   Donfield, Sharyne ^b   Lail, Alice ^b   Lynn, Henry S ^c   Daar, Eric S ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Rho   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CELL COUNT; CHILD; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; GENOTYPE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; COHORT STUDIES; DISEASE PROGRESSION; GENOTYPE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; RNA, VIRAL; VIREMIA;

EID: 11144330653     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/426513     Document Type: Article

References (45)

1. Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok AS. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996; 41:1265-72.
2. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injecting drug users. Medicine 1995; 74:212-20.
3. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA 2000; 284:450-6.
4. Daar ES, Lynn H, Donfield S, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 2001; 26:466-72.
5. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174:690-5.
6. Herrero-Martinez E, Sabin CA, Evans JG, Griffioen A, Lee CA, Emery VC. The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J Infect Dis 2002; 186:470-6.
7. Beld M, Penning M, Lukashov V, et al. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 1998; 244:504-12.
8. Eyster ME, Diamondstone LS, Lien J, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1993; 6:602-10.
9. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. Hepatology 1999; 30:1054-8.
10. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5.
11. Darby SC, Ewart DA, Giangrande PCF, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 1997; 350:1425-31.
12. Sabin CA, Telfer P, Phillips AN, Bhagani S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophiliac men. J Infect Dis 1997; 175:164-7.
13. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-5.
14. Piroth L, Grappin M, Cuzin L, et al. Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients. J Viral Hepat 2000; 7:302-8.
15. Piroth L, Duong M, Quantin C, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998; 12:381-8.
16. Lesens O, Deschenes M, Steben M, Belanger G, Tsoukas CM. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. J Infect Dis 1999; 179:1254-8.
17. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002; 288:199-206.
18. Rancinan C, Neau D, Saves M, et al. Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? AIDS 2002; 16:1357-62.
19. Macias J, Pineda JA, Leal M, et al. Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis 1998; 17:167-70.
20. Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, Hayes PC. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol 1998; 10:485-9.
21. Quan CM, Krajden M, Grigoriew GA, Salit IE. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis 1993; 17:117-9.
22. Staples CT Jr, Rimland D, Dudas D. Hepatitis C in the Atlanta VA Cohort Study: the effect of coinfection on survival. Clin Infect Dis 1999; 29:150-4.
23. Dorrucci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis 1995; 172: 1503-8.
24. Wright TL, Hollander H, Pu X, et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 1994; 20:1152-5.
25. Daar ES, Lynn H, Donfield S, et al. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 2001; 183:589-95.
26. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-82.
27. Hilgartner MW, Donfield SM, Willoughby A, et al. Hemophilia growth and development study: design, methods and entry data. Am J Pediatr Hematol Oncol 1993; 15:208-18.
28. + T lymphocytes, and the chemokine receptors CCR5 and CCR2b on HIV disease progression in hemophiliacs. J Acquir Immune Defic Syndr 1999; 21:317-25.
29. Centers for Disease Control and Prevention. Hemophilia surveillance system report. MMWR Morb Mortal Wkly Rep 1998; 1:1-14.
30. Dewar RL, Highbarger HC, Sarmiento MD, et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994; 170: 1172-9.
31. Trimoulet P, Halfen P, Pohier E, Khiri H, Chene G, Fleury H. Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum. J Clin Microbiol 2002; 40:2031-6.
32. Stuyver L, Wyseur A, Rombout A, et al. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene. Antimicrob Agents Chemother 1997; 41:284-91.
33. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immune deficiency. MMWR Morb Mortal Wkly Rep 1987; 36:51-15.
34. Berger A, Prondzinski MVD, Doerr HW, Rabenau H, Weber B. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J Med Virol 1996; 48:339-43.
35. Garcia F, Roldan C, Hernandez-Quero J, et al. Relationship between viral genotype and viral load in patients with chronic hepatitis C. Eur J Clin Microbiol Infect Dis 1996; 15:884-7.
36. Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr 2003; 33:356-64.
37. Hofmann H. Genotypes and virus load in patients with hepatitis C infection. Infection 1995; 23:133-8.
38. Longford N. Random coefficient models. Oxford: Clarendon Press, 1993.
39. Beld M, Penning M, McMorrow M, Gorgels J, van den Hock A, Goudsmit J. Different hepatitis C virus (HCV) RNA load profiles following serconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J Clin Microbiol 1998; 36:872-7.
40. Ahmed MM, Mutimer DJ, Martin B, Elias E, Wilde JT. Hepatitis C viral load, genotype and histological severity in patients with bleeding disorders. Haemophilia 1999; 5:49-55.
41. De Luca A, Bugarini R, Lepri AC, et al. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 2002; 162:2125-32.
42. + cell counts following highly active antiretroviral therapy in drug-naive patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis 2003; 22:675-80.
43. Piroth L, Bourgeois C, Dantin S, et al. Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients. AIDS 1999; 13:523-37.
44. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocyte/macrophages and lymphocytes. J Infect Dis 2000; 181:442-8.
45. Soriano V, Puoti M, Sulkowski M, et al. Care of patients with hepatitis C and HIV co-infection. AIDS 2004; 18:1-12.